Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Protein Detection System

By Drug Discovery Trends Editor | April 8, 2008

Millipore SNAP idMillipore Corporation introduces the SNAP i.d. protein detection system that allows researchers to produce higher quality Western blots 80% more quickly than with conventional immunodetection protocols.

By shortening the time required for blocking, washing, and antibody incubations to 30 minutes, the SNAP i.d. system allows researchers to optimize their immunodetection conditions for the highest quality results. The SNAP i.d. system is compatible with all membrane types and detection methods, such as chemiluminescence and fluorescence. Both sensitivity and specificity are equivalent or higher than standard immunodetection, with no additional reagent consumption required, according to Millipore. Antibody solutions can be collected and reused, for even more economical immunodetection

The SNAP i.d. system produces Western blots of high quality because its vacuum-driven technology and built-in flow distributor actively drive reagents through the membrane, ensuring even distribution. Three different sizes of blot holders accommodate up to three blots each, and two blot holders can be run in parallel. Researchers can process up to six blots in parallel, quickly optimize conditions, and greatly increase their protein detection throughput.

www.millipore.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50